How Pythia Labs launched on X
Posted Oct 27, 2026 by @joshlaniadoEngagement read Nov 19, 2026
Introducing Pythia-1, a frontier generative model for protein design. In our new study, we used it to rapidly design full-length human agonist and antagonist antibodies for hard-to-drug targets. We’re sharing complete sequences of all lead antibodies to support independent validation and further research. 1/8
- 332
- Likes
- 53
- Reposts
- 10
- Replies
- 10
- Quotes
- 225
- Bookmarks
How EPTA rated the launch
- Hook
- Editing / Creativity
- Copy
- Sentiment of launch
- Distribution strategy
How it compares
| Group | Launches | Median views | This one | Rank |
|---|---|---|---|---|
| Health and bio launches | 23 | 250.3K | 3.5x | #8 / 23 |
| Model releases | 120 | 251.3K | 3.5x | #30 / 120 |
| Accounts with Under 1K followers | 127 | 125.8K | 7x | #21 / 127 |
| Every launch | 963 | 147.7K | 6x | #163 / 963 |
What the numbers say
2.5 of every 10,000 viewers bookmarked it, below the directory median of 17. Bookmarks are the clearest sign a launch was worth coming back to.
The video runs 0:09, shorter than the median launch video at 0:53.
The post is 312 characters, longer than the median launch post at 302.
It went out on a Tuesday. Launches posted on Tuesdays have a median of 156.7K views; Fridays lead at 235.5K.
Comparable launches
2026-11-19 · Source: EPTA launch directory, epta.co/directory. Free to use with attribution (CC BY 4.0).